Even though QA is generally associated with a finished product, during the drug development process, there is always ongoing safety oversight at every stage. At Novartis, programs focus on early phase clinical trials, so Kaitlin has a unique perspective on QA as someone who is primarily involved at the beginning of the drug development process. Read more to learn about what inspired her to pursue a fellowship in early phase quality assurance and what she's most proud of from her first year.
Meet Mary Bylo, one of our Novartis CS&I fellows! Learn about what makes the Novartis program unique and how Mary decided to pursue a fellowship.
The MFN receives guidance and assistance from two Alumni Representatives who serve two year terms. For this article, we would like to introduce Melissa Laracy as our newest Alumni Representative. Melissa recently completed a fellowship at Biogen and has accepted a position with them post-Fellowship. In her article this week, Melissa reflects on her involvement as an MFN E-Board member and the value of having a network during her fellowship.
Joining any kind of post-graduate training program comes with many benefits. With the culmination of her fellowship in June, outgoing MFN President, Abimbola Cole asked to write about her experiences from her two year program. Continue reading to learn about her activities as a fellow and member of the MFN community.
From greater flexibility on rotations to opportunities to join and lead influential projects during your first year, there are many benefits of a fellowship with a smaller program or company. Learn more about MCPHS University's Sunovion fellowship, first year, Matthew Maulis's experience so far, and what he will be doing when he starts the second half of his program.